Lead the technical effort and define the strategic vision for patient-facing products, in partnership with product, biostatistics, clinical development, and regulatory/quality.
Design and build AI-based biomarkers on multimodal data — including whole-slide images, clinical variables, and molecular data — to predict patient outcomes, treatment benefit, and molecular traits.
Advance our core self-supervised foundation models and the downstream architectures built on them (multiple-instance learning, time-to-event / hazard models, segmentation and classification components), with generalization as a first-order objective.
Own score reproducibility across scanners, institutions, staining protocols, and patient populations.
Develop and integrate mechanistic interpretability methods to explain model decisions, build clinician trust, and drive actionable model improvements.
Architect tools and processes that streamline the end-to-end model development lifecycle — from prototyping through production deployment and monitoring — ensuring efficiency, reproducibility, regulatory compliance, and scale.
Author and defend regulatory and quality documentation, and represent AI in design and development reviews.
Plan and manage delivery: break multi-quarter programs into milestones, manage dependencies across AI, platform, biostatistics, and clinical teams, surface risk early, and hold submission and launch dates.
Publish in peer-reviewed journals and present at clinical and ML venues; support external academic and industry collaborations.
Mentor and coach machine-learning scientists and engineers, fostering their technical growth and collaboration skills, and raise the bar on scientific rigor, code quality, and written communication across the team.
5+ years of industry experience building deep learning systems in PyTorch (or TensorFlow).
2+ years of experience as a technical lead, launching and monitoring machine-learning products in production environments.
Demonstrated depth in oncology and biomarker development: familiarity with cancer biology and treatment pathways, clinical endpoints, risk stratification, and what makes a biomarker clinically actionable.
Demonstrated project management ability — scoping, sequencing, and managing dependencies and risk across multiple teams on dated deliverables.
Proven ability to communicate complex ML concepts effectively to cross-functional, non-ML collaborators.
Experience mentoring or managing ML scientists and engineers.
Experience building ML on complex clinical data — medical imaging, multi-omics, or longitudinal patient records — including weakly supervised learning and handling variation across sites, devices, and protocols.
Experience developing ML in a regulated environment — FDA 510(k)/De Novo, CE/UKCA, SaMD, design controls, or CLIA/LDT validation.
Experience with self-supervised representation learning (e.g., DINOv3) and adapting medical foundation models to downstream clinical tasks.
Experience with data from randomized controlled trials and multi-institutional clinical cohorts.
Peer-reviewed publications and conference presentations; history of external academic or industry collaborations.
Experience with cloud-scale training and workflow orchestration (e.g., Flyte / Union, Kubernetes, AWS), experiment tracking, and reproducible ML pipelines.
Job details are sourced from the employer's original posting.
Open job postingAbout the company
Artera is a SaaS digital health leader redefining patient communications. Artera is trusted by 800+ healthcare systems and federal agencies to facilitate approximately 2.2 billion messages annually, reaching 100+ million patients. The Artera platform integrates across a healthcare organization's tech stack, EHRs and third-party vendors to unify, simplify and orchestrate digital communications into the patient's preferred channel (texting, email, IVR, and webchat), in 109+ languages. The Artera impact: more efficient staff, more profitable organizations and a more harmonious patient experience. Founded in 2015, Artera is based in Santa Barbara, California and has been named a Deloitte Technology Fast 500 company (2021, 2022, 2023), and ranked on the Inc. 5000 list of fastest-growing private companies for four consecutive years. Artera is a two-time Best in KLAS winner in Patient Outreach.